Proxy Votes Now

Home › Funds › Vanguard › Vanguard Growth and Income Fund

Vanguard Growth and Income Fund (VGIAX) proxy voting record 2025-2026

Fund family: Vanguard · Filed by VANGUARD QUANTITATIVE FUNDS (CIK 799127) · SEC series S000002913

Share classes and tickers: VGIAX (C000007980), VQNPX (C000007979)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 7,986 with, 281 against, 1 abstentions (not counted as with management); 19 items carried no recommendation; 94 split votes are in neither count. Shareholder proposals: 101 FOR, 167 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Vanguard as a whole

The same two figures as Vanguard’s manager page (1,379,791 ballot items across 136 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsVanguardItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)92.6%7,77194.5%1,082,514
Backed environmental and social shareholder proposals at US companies11.0%1270.9%6,718

Where this fund voted differently from most Vanguard funds

Each ballot item this fund voted is set against the votes of the other Vanguard funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Vanguard funds on 548 items (6.8% of the 8,006 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Vanguard fundsMgmtResult
Amgen Inc.2026-05-19Shareholder Stockholder proposal to require an independent board chairman.ForAGAINST — 34 of 34 Vanguard fundsForNot approved, 17.7% support
The Bank of New York Mellon Corporation2026-04-14Election of Directors: Joseph J. EchevarriaAgainstFOR — 33 of 33 Vanguard fundsAgainstElected, 90.4% support
Expedia Group, Inc.2026-06-17Approval, on an advisory basis, of the compensation of Expedia Group's named executive officers.AgainstFOR — 33 of 33 Vanguard fundsForApproved, 89.4% support
ConocoPhillips2026-05-12Shareholder Stockholder Proposal - Independent Board Chairman.ForAGAINST — 31 of 31 Vanguard fundsAgainstNot approved, 28.0% support
HCA Healthcare, Inc.2026-04-23Shareholder Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences.ForAGAINST — 30 of 30 Vanguard fundsForNot approved, 10.9% support
HCA Healthcare, Inc.2026-04-23Election of Directors: Hugh F. JohnstonAgainstFOR — 30 of 30 Vanguard fundsForPassed (calculated), 91.9% support
HCA Healthcare, Inc.2026-04-23Election of Directors: Nancy-Ann DeParleAgainstFOR — 30 of 30 Vanguard fundsForPassed (calculated), 88.6% support
Honeywell International Inc.2026-05-22Shareholder Shareowner Proposal - Shareholder Right to Act by Written Consent.ForAGAINST — 31 of 31 Vanguard fundsAgainstNot approved, 32.1% support
Autodesk, Inc.2026-06-17Approval of an amendment of our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law.AgainstFOR — 30 of 30 Vanguard fundsAgainstPassed (calculated), 81.5% support
United Airlines Holdings, Inc.2026-05-19Election of Directors Named in Proxy Statement: Edward M. PhilipAgainstFOR — 31 of 31 Vanguard fundsAgainstPassed (calculated), 92.3% support
Teradyne, Inc.2026-05-08To elect the nine nominees named in the accompanying proxy statement to the Board of Directors to serve as directors for a one-year term: Marilyn MatzAgainstFOR — 30 of 30 Vanguard fundsAgainstElected, 92.8% support
Southwest Airlines Co.2026-05-07Election of Directors: Christopher P. ReynoldsAgainstFOR — 31 of 31 Vanguard fundsAgainstPassed (calculated), 61.2% support
Tyson Foods, Inc.2026-02-05Election of Directors: Barbara A. TysonAgainstFOR — 31 of 31 Vanguard fundsAgainstPassed (calculated), 95.2% support
Tyson Foods, Inc.2026-02-05Election of Directors: Cheryl S. MillerAgainstFOR — 31 of 31 Vanguard fundsAgainstPassed (calculated), 91.6% support
Tyson Foods, Inc.2026-02-05Election of Directors: John H. TysonAgainstFOR — 31 of 31 Vanguard fundsAgainst—
Tyson Foods, Inc.2026-02-05Election of Directors: John R. TysonAgainstFOR — 31 of 31 Vanguard fundsAgainst—
Tyson Foods, Inc.2026-02-05Election of Directors: Maria Claudia BorrasAgainstFOR — 31 of 31 Vanguard fundsAgainstPassed (calculated), 94.3% support
Tyson Foods, Inc.2026-02-05Election of Directors: Maria N. MartinezAgainstFOR — 31 of 31 Vanguard fundsAgainstPassed (calculated), 94.4% support
Tyson Foods, Inc.2026-02-05Election of Directors: Mike BeebeAgainstFOR — 31 of 31 Vanguard fundsAgainstPassed (calculated), 94.2% support
Tyson Foods, Inc.2026-02-05Election of Directors: Olivia L. TysonAgainstFOR — 31 of 31 Vanguard fundsAgainstPassed (calculated), 91.7% support
Tyson Foods, Inc.2026-02-05To approve the amendment and restatement of the Tyson Foods, Inc. 2000 Stock Incentive Plan, a copy of which is attached to the Proxy Statement as Exhibit A.AgainstFOR — 31 of 31 Vanguard fundsAgainstPassed (calculated), 91.8% support
CDW Corporation2026-05-21Shareholder To consider and act upon the stockholder proposal, if properly presented at the meeting, regarding independent Board chair requirements.ForAGAINST — 31 of 31 Vanguard fundsAgainstNot approved, 42.7% support
Alphabet Inc.2026-06-05Election of ten directors: Frances H. ArnoldAgainstFOR — 28 of 28 Vanguard fundsAgainstElected, 90.1% support
Alphabet Inc.2026-06-05Election of ten directors: John L. HennessyAgainstFOR — 28 of 28 Vanguard fundsAgainstElected, 85.2% support
Intel Corporation2026-05-13Approval of amendment and restatement of the 2006 Equity Incentive Plan.AgainstFOR — 29 of 29 Vanguard fundsAgainstPassed (calculated), 84.3% support
Show the next 475
Items 26 to 500.
CompanyMeetingItemThis fundMost Vanguard fundsMgmtResult
Caterpillar, Inc.2026-06-10Shareholder Shareholder Proposal - Shareholder Right to Act by Written ConsentForAGAINST — 28 of 28 Vanguard fundsAgainstNot approved, 39.5% support
McDonald's Corporation2026-05-20Shareholder Advisory Vote on Shareholders' Right to Act by Written Consent.ForAGAINST — 28 of 28 Vanguard fundsAgainstFailed (calculated), 41.9% support
Verizon Communications Inc.2026-05-21Election of Directors: Shellye ArchambeauAgainstFOR — 27 of 27 Vanguard fundsAgainstElected, 91.3% support
Kimberly-Clark Corporation2026-05-14Shareholder Stockholder proposal to require Independent Board ChairForAGAINST — 27 of 27 Vanguard fundsAgainstNot approved, 33.8% support
PayPal Holdings, Inc.2026-05-19Approval of the PayPal Holdings, Inc. 2026 Equity Incentive Award Plan.AgainstFOR — 27 of 27 Vanguard fundsAgainstApproved, 72.7% support
Fifth Third Bancorp2026-04-21Election of 16 members of the Board of Directors to serve until the Annual Meeting of Shareholders in 2027: Nicholas K. AkinsAgainstFOR — 29 of 29 Vanguard fundsAgainstPassed (calculated), 95.6% support
Expedia Group, Inc.2026-06-17Election of Directors: Alex von FurstenbergWithholdFOR — 27 of 27 Vanguard fundsForPassed (calculated), 92.9% support
Expedia Group, Inc.2026-06-17Election of Directors: Craig JacobsonWithholdFOR — 27 of 27 Vanguard fundsForPassed (calculated), 78.2% support
Dow Inc.2026-04-09Approval of the Amendment to the 2019 Stock Incentive PlanAgainstFOR — 27 of 27 Vanguard fundsAgainstApproved, 76.6% support
First Solar, Inc.2026-05-13Election of Directors: Paul H. StebbinsAgainstFOR — 28 of 28 Vanguard fundsAgainstElected, 77.7% support
Alphabet Inc.2026-06-05Approval of the amendment and restatement of Alphabet's Amended and Restated 2021 Stock Plan to increase the share reserve by 200,000,000 shares of Class C capital stockAgainstFOR — 26 of 26 Vanguard fundsAgainstApproved, 90.4% support
JPMorgan Chase & Co.2026-05-19Shareholder Independent board chairmanForAGAINST — 37 of 38 Vanguard fundsAgainstNot approved, 35.4% support
Salesforce, Inc.2026-05-28Amendment and restatement of our 2013 Equity Incentive Plan to increase the number of shares reserved for issuance and extend the plan term.AgainstFOR — 26 of 26 Vanguard fundsAgainstPassed (calculated), 75.8% support
T-Mobile US, Inc.2026-06-16Election of Directors: G. Michael SievertWithholdFOR — 26 of 26 Vanguard fundsAgainstPassed (calculated), 90.2% support
T-Mobile US, Inc.2026-06-16Election of Directors: Letitia A. LongForWITHHOLD — 26 of 26 Vanguard fundsForPassed (calculated), 93.1% support
T-Mobile US, Inc.2026-06-16Election of Directors: Srinivasan GopalanWithholdFOR — 26 of 26 Vanguard fundsAgainstPassed (calculated), 92.2% support
T-Mobile US, Inc.2026-06-16Election of Directors: Teresa A. TaylorForWITHHOLD — 26 of 26 Vanguard fundsForPassed (calculated), 88.0% support
T-Mobile US, Inc.2026-06-16Election of Directors: Thorsten LangheimWithholdFOR — 26 of 26 Vanguard fundsAgainstPassed (calculated), 89.8% support
T-Mobile US, Inc.2026-06-16Election of Directors: Timotheus HottgesWithholdFOR — 26 of 26 Vanguard fundsAgainstPassed (calculated), 89.7% support
Chubb Limited2026-05-21Election of Evan G. Greenberg as Chairman of the Board of DirectorsAgainstFOR — 26 of 26 Vanguard fundsAgainstPassed (calculated), 82.3% support
AppLovin Corporation2026-06-03Election of Directors: ADAM FOROUGHIWithholdFOR — 26 of 26 Vanguard fundsAgainstPassed (calculated), 96.7% support
AppLovin Corporation2026-06-03Election of Directors: EDUARDO VIVASWithholdFOR — 26 of 26 Vanguard fundsAgainstPassed (calculated), 95.6% support
The Bank of New York Mellon Corporation2026-04-14Advisory resolution to approve the 2025 compensation of our named executive officers.AgainstFOR — 38 of 39 Vanguard fundsAgainstPassed (calculated), 55.6% support
Regeneron Pharmaceuticals, Inc.2026-06-12Election of Directors: Joseph L. Goldstein, M.D.AgainstFOR — 25 of 25 Vanguard fundsAgainstElected, 70.1% support
The Travelers Companies, Inc.2026-05-20Shareholder Shareholder proposal relating to an independent board chairman, if presented at the Annual Meeting of Shareholders.ForAGAINST — 26 of 26 Vanguard fundsAgainstFailed (calculated), 21.5% support
Steel Dynamics, Inc.2026-05-06Shareholder Shareholder proposal - avoid political spending brand damageForAGAINST — 25 of 25 Vanguard fundsAgainstFailed (calculated), 39.3% support
Otis Worldwide Corporation2026-05-27Shareholder Shareholder proposal regarding reporting on political contributions and expendituresForAGAINST — 26 of 26 Vanguard fundsAgainstNot approved, 45.6% support
CMS Energy Corporation2026-05-08Shareholder Vote on a Shareholder Proposal: Shareholder Right to Act by Written Consent.ForAGAINST — 25 of 25 Vanguard fundsAgainstNot approved, 36.0% support
Pinnacle Financial Partners, Inc.2025-11-06A proposal to approve, on an advisory (non-binding) basis, the merger-related compensation payments that will or may be paid to Pinnacle's named executive officers in connection with the transactions contemplated by the merger agreement.AgainstFOR — 25 of 25 Vanguard fundsAgainst—
Trimble Inc.2026-05-26Election of Directors: Kaigham (Ken) GabrielWithholdFOR — 25 of 25 Vanguard fundsAgainstElected, 66.7% support
Trimble Inc.2026-05-26Election of Directors: Kara SpragueWithholdFOR — 25 of 25 Vanguard fundsAgainstElected, 67.2% support
Trimble Inc.2026-05-26Election of Directors: Thomas SweetWithholdFOR — 25 of 25 Vanguard fundsAgainstElected, 67.2% support
First BanCorp.2026-05-06Election of Directors: Roberto R. HerenciaForAGAINST — 26 of 26 Vanguard fundsFor—
Meta Platforms, Inc.2026-05-27Election of Directors: Andrew W. HoustonWithholdFOR — 24 of 24 Vanguard fundsAgainstElected, 91.1% support
Meta Platforms, Inc.2026-05-27Election of Directors: Mark ZuckerbergWithholdFOR — 24 of 24 Vanguard fundsAgainstElected, 93.6% support
Meta Platforms, Inc.2026-05-27Election of Directors: Peggy AlfordWithholdFOR — 24 of 24 Vanguard fundsAgainstElected, 86.4% support
Meta Platforms, Inc.2026-05-27Election of Directors: Tony XuWithholdFOR — 24 of 24 Vanguard fundsAgainstElected, 91.2% support
Oracle Corporation2025-11-18Election of Directors: Awo AbloWithholdFOR — 23 of 23 Vanguard fundsAgainstElected, 83.9% support
Oracle Corporation2025-11-18Election of Directors: Bruce R. ChizenWithholdFOR — 23 of 23 Vanguard fundsAgainstElected, 76.1% support
International Business Machines Corporation2026-04-28Shareholder Stockholder Proposal Requesting a Right to Act by Written ConsentForAGAINST — 24 of 24 Vanguard fundsAgainstFailed (calculated), 37.3% support
International Business Machines Corporation2026-04-28Approval of 2026 Long-Term Performance PlanAgainstFOR — 24 of 24 Vanguard fundsAgainstPassed (calculated), 75.8% support
Dell Technologies Inc.2026-06-25Election of Group I Directors: David W. DormanWithholdFOR — 23 of 23 Vanguard fundsAgainstElected, 98.3% support
Dell Technologies Inc.2026-06-25Election of Group I Directors: Ellen J. KullmanWithholdFOR — 23 of 23 Vanguard fundsAgainstElected, 97.0% support
Dell Technologies Inc.2026-06-25Election of Group I Directors: Michael S. DellWithholdFOR — 23 of 23 Vanguard fundsAgainstElected, 98.2% support
S&P Global Inc.2026-05-20Shareholder Vote on a shareholder proposal to reduce the stock ownership threshold for calling a special shareholder meeting;ForAGAINST — 23 of 23 Vanguard fundsAgainstFailed (calculated), 40.8% support
AppLovin Corporation2026-06-03Election of Directors: BARBARA MESSINGWithholdFOR — 23 of 23 Vanguard fundsAgainstPassed (calculated), 95.7% support
AppLovin Corporation2026-06-03Election of Directors: HERALD CHENWithholdFOR — 23 of 23 Vanguard fundsAgainstPassed (calculated), 96.3% support
AppLovin Corporation2026-06-03Election of Directors: MARGARET GEORGIADISWithholdFOR — 23 of 23 Vanguard fundsAgainstPassed (calculated), 92.1% support
AppLovin Corporation2026-06-03Election of Directors: MAYNARD WEBBWithholdFOR — 23 of 23 Vanguard fundsAgainstPassed (calculated), 95.7% support
Comcast Corporation2026-06-10Election of Directors: Jeffrey A. HonickmanWithholdFOR — 23 of 23 Vanguard fundsAgainstElected, 87.9% support
Comcast Corporation2026-06-10Election of Directors: Kenneth J. BaconWithholdFOR — 23 of 23 Vanguard fundsAgainstElected, 80.4% support
Comcast Corporation2026-06-10Election of Directors: Madeline S. BellWithholdFOR — 23 of 23 Vanguard fundsAgainstElected, 88.9% support
General Motors Company2026-06-02Proposal to Approve Amendment No. 2 to the Company's 2020 Long-Term Incentive Plan to Increase the Number of Shares Available for Issuance ThereunderAgainstFOR — 23 of 23 Vanguard fundsAgainstApproved, 71.0% support
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: Dara TresederAgainstFOR — 23 of 23 Vanguard fundsAgainstPassed (calculated), 95.0% support
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: Jonathan RubinsteinAgainstFOR — 23 of 23 Vanguard fundsAgainstPassed (calculated), 90.7% support
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: Robert ZoellickAgainstFOR — 23 of 23 Vanguard fundsAgainstPassed (calculated), 95.0% support
Ford Motor Company2026-05-14Shareholder A shareholder proposal relating to public disclosure by share class of voting results on matters subject to a shareholder vote.ForAGAINST — 24 of 24 Vanguard fundsAgainstNot approved, 26.5% support
Ford Motor Company2026-05-14Election of Directors: William Clay Ford, Jr.AgainstFOR — 24 of 24 Vanguard fundsAgainstPassed (calculated), 91.1% support
Ford Motor Company2026-05-14Election of Directors: William E. KennardAgainstFOR — 24 of 24 Vanguard fundsAgainstPassed (calculated), 81.8% support
Yum! Brands, Inc.2026-05-14Shareholder Shareholder Proposal to Reduce the Percentage of Shares Required to Call a Special Meeting.ForAGAINST — 23 of 23 Vanguard fundsAgainstNot approved, 37.7% support
Eversource Energy2026-05-06Shareholder Vote on a shareholder proposal titled "Independent Board Chairman," if properly brought before the meeting.ForAGAINST — 23 of 23 Vanguard fundsAgainstNot approved, 26.5% support
Eversource Energy2026-05-06Election of Trustees: David H. LongAgainstFOR — 23 of 23 Vanguard fundsAgainstElected, 91.7% support
Edison International2026-04-23Shareholder Shareholder Proposal Regarding Retention of EquityForAGAINST — 24 of 24 Vanguard fundsAgainstNot approved, 37.4% support
Gen Digital Inc.2025-09-09Election of Directors: Eric K. BrandtAgainstFOR — 24 of 24 Vanguard fundsForElected, 90.0% support
CF Industries Holdings, Inc.2026-04-28Shareholder Shareholder proposal regarding shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting.ForAGAINST — 23 of 23 Vanguard fundsAgainstPassed (calculated), 51.6% support
DocuSign, Inc.2026-06-01Election of Class II Directors: Allan ThygesenAgainstFOR — 23 of 23 Vanguard fundsAgainstPassed (calculated), 77.6% support
DocuSign, Inc.2026-06-01Election of Class II Directors: Cain A. HayesAgainstFOR — 23 of 23 Vanguard fundsAgainstPassed (calculated), 72.7% support
DocuSign, Inc.2026-06-01Election of Class II Directors: James BeerAgainstFOR — 23 of 23 Vanguard fundsAgainstPassed (calculated), 71.8% support
Hormel Foods Corporation2026-01-27Approve the Hormel Foods Corporation 2026 Equity and Incentive Compensation Plan.AgainstFOR — 24 of 24 Vanguard fundsAgainst—
ADT Inc.2026-05-27Election of Directors To be elected for terms expiring in 2027: Danielle TiedtWithholdFOR — 24 of 24 Vanguard fundsAgainstPassed (calculated), 78.1% support
Laureate Education, Inc.2026-05-21To elect nine (9) directors, each of whom shall hold office for a one year term until the 2027 Annual Meeting of Stockholders: Andrew B. CohenWithholdFOR — 23 of 23 Vanguard fundsAgainstPassed (calculated), 79.3% support
Laureate Education, Inc.2026-05-21To elect nine (9) directors, each of whom shall hold office for a one year term until the 2027 Annual Meeting of Stockholders: Ian K. SnowWithholdFOR — 23 of 23 Vanguard fundsAgainstPassed (calculated), 75.2% support
Lumen Technologies, Inc.2026-05-20Shareholder Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill.ForAGAINST — 23 of 23 Vanguard fundsAgainstNot approved, 47.8% support
Visa Inc.2026-01-27Shareholder Shareholder proposal on shareholder right to act by written consent.ForAGAINST — 33 of 34 Vanguard fundsAgainstNot approved, 33.0% support
Bank of America Corporation2026-05-04Shareholder Shareholder proposal requesting independent board chairForAGAINST — 33 of 34 Vanguard fundsAgainstFailed (calculated), 32.6% support
Arista Networks, Inc.2026-05-29Election of Directors: Greg LavenderWithholdFOR — 21 of 21 Vanguard fundsAgainstElected, 79.1% support
Arista Networks, Inc.2026-05-29Election of Directors: Lewis ChewWithholdFOR — 21 of 21 Vanguard fundsAgainstElected, 78.3% support
Arista Networks, Inc.2026-05-29Election of Directors: Mark B. TempletonWithholdFOR — 21 of 21 Vanguard fundsAgainstElected, 63.3% support
Stryker Corporation2026-05-06Election Directors: Emmanuel P. MacedaAgainstFOR — 22 of 22 Vanguard fundsAgainstElected, 81.9% support
AppLovin Corporation2026-06-03Approval, on an advisory basis, of the compensation of our named executive officers.AgainstFOR — 32 of 33 Vanguard fundsAgainstApproved, 92.3% support
Equinix, Inc.2026-05-13Shareholder Consideration and vote upon a stockholder proposal, if properly presented at the Annual Meeting, related to lowering the stock ownership threshold required to call a special meetingForAGAINST — 21 of 21 Vanguard fundsAgainstNot approved, 30.4% support
United Parcel Service, Inc.2026-05-07To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: William JohnsonAgainstFOR — 21 of 21 Vanguard fundsAgainstElected, 76.1% support
O'Reilly Automotive, Inc.2026-05-14Shareholder Shareholder proposal entitled "Avoid Brand Damage due to Corporate Political Spending."ForAGAINST — 22 of 22 Vanguard fundsAgainstNot approved, 44.2% support
Simon Property Group, Inc.2026-05-13Advisory Vote to Approve the Compensation of our Named Executive Officers.AgainstFOR — 33 of 34 Vanguard fundsAgainstApproved, 69.6% support
WEC Energy Group, Inc.2026-05-07Shareholder Stockholder proposal to govern by majority voteForAGAINST — 22 of 22 Vanguard fundsAgainstNot approved, 37.6% support
Coinbase Global, Inc.2026-06-16Election of Directors: Brian ArmstrongWithholdFOR — 21 of 21 Vanguard fundsAgainstElected, 97.9% support
Coinbase Global, Inc.2026-06-16Election of Directors: Frederick Ernest Ehrsam IIIWithholdFOR — 21 of 21 Vanguard fundsAgainstElected, 97.0% support
Coinbase Global, Inc.2026-06-16Election of Directors: Gokul RajaramWithholdFOR — 21 of 21 Vanguard fundsAgainstElected, 96.1% support
Coinbase Global, Inc.2026-06-16Election of Directors: Marc L. AndreessenWithholdFOR — 21 of 21 Vanguard fundsAgainstElected, 97.1% support
West Pharmaceutical Services, Inc.2026-05-04Shareholder Shareholder proposal regarding an independent Board Chair policy.ForAGAINST — 22 of 22 Vanguard fundsAgainstNot approved, 46.4% support
FirstEnergy Corp.2026-05-20Shareholder Independent Board ChairmanForAGAINST — 22 of 22 Vanguard fundsAgainstNot approved, 32.8% support
FirstEnergy Corp.2026-05-20Election of Directors: Paul KaletaAgainstFOR — 22 of 22 Vanguard fundsAgainstElected, 86.8% support
Zoom Communications, Inc.2026-06-11Elect two nominees for Class I director to serve until our 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Lieut. Gen. H.R. McMasterWithholdFOR — 21 of 21 Vanguard fundsAgainstElected, 77.3% support
United Therapeutics Corporation2026-06-26Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan.AgainstFOR — 21 of 21 Vanguard fundsAgainstPassed (calculated), 72.0% support
Universal Health Services, Inc.2026-05-20Shareholder Stockholder proposal to adopt a policy requiring Universal Health Services, Inc. to publicly disclose its workforce diversity, if properly presented at the meeting.ForAGAINST — 22 of 22 Vanguard fundsFor—
Universal Health Services, Inc.2026-05-20Shareholder Stockholder proposal to report votes based on UHS shareholder money at risk, if properly presented at the meeting.ForAGAINST — 22 of 22 Vanguard fundsAgainstFailed (calculated), 4.7% support
Align Technology, Inc.2026-05-20Ratification of Special Meeting Provision in our BylawsAgainstFOR — 21 of 21 Vanguard fundsAgainstPassed (calculated), 73.7% support
Virtu Financial, Inc.2026-06-10Election of Directors: Joanne M. MinieriWithholdFOR — 21 of 21 Vanguard fundsAgainstElected, 96.1% support
Sanmina Corporation2026-03-09To elect eight directors of Sanmina Corporation: Mythili SankaranAgainstFOR — 22 of 22 Vanguard fundsAgainstPassed (calculated), 56.9% support
Amneal Pharmaceuticals, Inc.2026-05-06Election of Directors: Deb AutorAgainstFOR — 21 of 21 Vanguard fundsAgainstElected, 92.3% support
Amneal Pharmaceuticals, Inc.2026-05-06Election of Directors: J. Kevin BuchiAgainstFOR — 21 of 21 Vanguard fundsAgainstElected, 90.9% support
Amneal Pharmaceuticals, Inc.2026-05-06Election of Directors: Jeff GeorgeAgainstFOR — 21 of 21 Vanguard fundsAgainstElected, 92.3% support
Amneal Pharmaceuticals, Inc.2026-05-06Election of Directors: John KielyAgainstFOR — 21 of 21 Vanguard fundsAgainstElected, 88.3% support
Amneal Pharmaceuticals, Inc.2026-05-06Election of Directors: Paul MeisterAgainstFOR — 21 of 21 Vanguard fundsAgainstElected, 87.5% support
Amneal Pharmaceuticals, Inc.2026-05-06Election of Directors: Shlomo YanaiAgainstFOR — 21 of 21 Vanguard fundsAgainstElected, 92.3% support
Doximity, Inc.2025-08-28To elect two Class I Directors to serve until the annual meeting of stockholders to be held in 2028 or until their successors are duly elected and qualified: Jeffrey TangneyWithholdFOR — 22 of 22 Vanguard fundsAgainstElected, 97.0% support
Doximity, Inc.2025-08-28To elect two Class I Directors to serve until the annual meeting of stockholders to be held in 2028 or until their successors are duly elected and qualified: Kira WamplerWithholdFOR — 22 of 22 Vanguard fundsAgainstElected, 91.7% support
Pediatrix Medical Group, Inc.2026-05-07Elect nine Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified: John M. Starcher, Jr.AgainstFOR — 22 of 22 Vanguard fundsAgainstElected, 64.1% support
The Boston Beer Company, Inc.2026-05-27Election of Directors: Cynthia L. SwansonWithholdFOR — 21 of 21 Vanguard fundsAgainst—
The Boston Beer Company, Inc.2026-05-27Election of Directors: Joseph H. JordanWithholdFOR — 21 of 21 Vanguard fundsAgainst—
The Boston Beer Company, Inc.2026-05-27Election of Directors: Meghan V. JoyceWithholdFOR — 21 of 21 Vanguard fundsAgainst—
Inspire Medical Systems, Inc.2026-04-30Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan.AgainstFOR — 22 of 22 Vanguard fundsAgainstApproved, 62.0% support
Inspire Medical Systems, Inc.2026-04-30Election of Class II Directors: Gary L. EllisWithholdFOR — 21 of 21 Vanguard fundsAgainstElected, 74.6% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Debra L. LeeWithholdFOR — 22 of 22 Vanguard fundsAgainstPassed (calculated), 68.2% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Geoffrey Y. YangWithholdFOR — 22 of 22 Vanguard fundsAgainstPassed (calculated), 68.9% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Kenneth W. LoweWithholdFOR — 22 of 22 Vanguard fundsAgainstPassed (calculated), 68.8% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Paul A. GouldWithholdFOR — 22 of 22 Vanguard fundsAgainstPlurality election, 48.2% support
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Richard W. FisherWithholdFOR — 22 of 22 Vanguard fundsAgainstPassed (calculated), 68.6% support
Tesla, Inc.2025-11-06A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified: Ira EhrenpreisAgainstFOR — 20 of 20 Vanguard fundsAgainstElected, 65.0% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Charlotte GuymanWithholdFOR — 20 of 20 Vanguard fundsAgainstPassed (calculated), 87.6% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Kenneth I. ChenaultWithholdFOR — 20 of 20 Vanguard fundsAgainstPassed (calculated), 94.3% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Stephen B. BurkeWithholdFOR — 20 of 20 Vanguard fundsAgainstPassed (calculated), 92.7% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Susan L. DeckerWithholdFOR — 20 of 20 Vanguard fundsAgainstPassed (calculated), 88.8% support
Berkshire Hathaway Inc.2026-05-02Election of Directors: Thomas S. Murphy, Jr.WithholdFOR — 20 of 20 Vanguard fundsAgainstPassed (calculated), 94.4% support
Arista Networks, Inc.2026-05-29Approval, on an advisory basis, of the compensation of our named executive officers.AgainstFOR — 30 of 31 Vanguard fundsAgainstApproved, 60.4% support
The Sherwin-Williams Company2026-04-22Shareholder Shareholder Proposal Regarding Shareholder Ability to Call a Special MeetingForAGAINST — 20 of 20 Vanguard fundsAgainstNot approved, 43.3% support
Crown Castle Inc.2026-05-20The non-binding, advisory vote to approve the compensation of the Company's named executive officers.AgainstFOR — 31 of 32 Vanguard fundsAgainstApproved, 88.4% support
United Airlines Holdings, Inc.2026-05-19Shareholder Advisory vote on stockholder proposal entitled "Shareholder Right to Act by Written Consent".ForAGAINST — 30 of 31 Vanguard fundsAgainstNot approved, 39.6% support
Everpure, Inc.2026-06-10Election of three Class II directors to serve until our Annual Meeting of Stockholders in 2029: Roxanne TaylorWithholdFOR — 20 of 20 Vanguard fundsAgainstElected, 54.5% support
Jabil Inc.2026-01-22Shareholder Vote on a stockholder proposal requesting stockholder right to act by written consent.ForAGAINST — 30 of 31 Vanguard fundsAgainstNot approved, 38.5% support
The Gap, Inc.2026-05-12Election of Directors: Robert J. FisherAgainstFOR — 20 of 20 Vanguard fundsAgainstElected, 77.4% support
Crocs, Inc.2026-06-09Approval of the Crocs, Inc. 2026 Equity Incentive Plan.AgainstFOR — 20 of 20 Vanguard fundsAgainstApproved, 77.8% support
Fresh Del Monte Produce Inc.2026-06-04Elect two director nominees for a three-year term expiring at the 2029 Annual General Meeting of Shareholders: Lori Tauber MarcusAgainstFOR — 20 of 20 Vanguard fundsAgainstPassed (calculated), 85.5% support
Fresh Del Monte Produce Inc.2026-06-04Elect two director nominees for a three-year term expiring at the 2029 Annual General Meeting of Shareholders: Michael J. BerthelotAgainstFOR — 20 of 20 Vanguard fundsAgainstPassed (calculated), 78.6% support
Moderna, Inc.2026-05-06To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: SaAgainstFOR — 19 of 19 Vanguard fundsAgainstElected, 81.0% support
Bloom Energy Corporation2026-05-21Election of our four Class II Directors: Barbara BurgerWithholdFOR — 19 of 19 Vanguard fundsAgainstElected, 84.2% support
Bloom Energy Corporation2026-05-21Election of our four Class II Directors: Eddy ZervigonWithholdFOR — 19 of 19 Vanguard fundsAgainstElected, 76.8% support
CBRE Group, Inc.2026-05-21Shareholder Stockholder proposal regarding our stockholders' ability to call special stockholder meetings.ForAGAINST — 29 of 30 Vanguard fundsAgainst—
Skyworks Solutions, Inc.2026-05-13To approve, on an advisory basis, the compensation of the Company's named executive officers, as described in the Company's Proxy Statement.AgainstFOR — 28 of 29 Vanguard fundsAgainstNot approved, 49.8% support
Fidelity National Financial, Inc.2026-06-10Election of Class III directors to serve until the 2029 annual meeting of shareholders: William P. Foley, IIWithholdFOR — 19 of 19 Vanguard fundsAgainstPassed (calculated), 78.5% support
Corcept Therapeutics Incorporated2026-05-21Election of Directors: Daniel N. Swisher, Jr.WithholdFOR — 19 of 19 Vanguard fundsAgainstElected, 87.5% support
Corcept Therapeutics Incorporated2026-05-21Election of Directors: David L. MahoneyWithholdFOR — 19 of 19 Vanguard fundsAgainstElected, 66.1% support
Corcept Therapeutics Incorporated2026-05-21Election of Directors: G. Leonard Baker, Jr.WithholdFOR — 19 of 19 Vanguard fundsAgainstElected, 84.0% support
Corcept Therapeutics Incorporated2026-05-21Election of Directors: Gregg AltonWithholdFOR — 19 of 19 Vanguard fundsAgainstElected, 87.9% support
Eastman Chemical Company2026-05-07Shareholder Advisory Vote on Stockholder Proposal Regarding Lowering the Threshold for Calling Special Shareholder Meetings to 10%ForAGAINST — 19 of 19 Vanguard fundsAgainstNot approved, 27.9% support
Albertsons Companies, Inc.2025-08-07Election of Directors: Sharon AllenAgainstFOR — 19 of 19 Vanguard fundsAgainstElected, 82.2% support
Celanese Corporation2026-04-16Election of Directors: Deborah J. KissireAgainstFOR — 19 of 19 Vanguard fundsForElected, 98.3% support
Celanese Corporation2026-04-16Election of Directors: Ganesh MoorthyAgainstFOR — 19 of 19 Vanguard fundsForElected, 98.3% support
DENTSPLY SIRONA Inc.2026-06-02Election of Directors: Donald J. ZurbayAgainstFOR — 19 of 19 Vanguard fundsAgainstPassed (calculated), 69.5% support
Palantir Technologies Inc.2026-06-03Shareholder Stockholder proposal entitled "Political Spending Disclosure," if properly presented at the Annual Meeting.ForAGAINST — 18 of 18 Vanguard fundsAgainstNot approved, 26.2% support
Palantir Technologies Inc.2026-06-03Election of Directors: Alexander KarpWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 93.1% support
Palantir Technologies Inc.2026-06-03Election of Directors: Alexander MooreWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 85.5% support
Palantir Technologies Inc.2026-06-03Election of Directors: Alexandra SchiffWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 86.1% support
Palantir Technologies Inc.2026-06-03Election of Directors: Peter ThielWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 86.9% support
Palantir Technologies Inc.2026-06-03Election of Directors: Stephen CohenWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 93.0% support
Lockheed Martin Corporation2026-05-12Shareholder Stockholder Proposal Requiring Independent Board ChairmanForAGAINST — 27 of 28 Vanguard fundsAgainstNot approved, 35.8% support
Cloudflare, Inc.2026-06-30Election of Class I directors: Karim LakhaniWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 79.7% support
Boston Scientific Corporation2026-04-30Shareholder Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."ForAGAINST — 27 of 28 Vanguard fundsAgainstNot approved, 42.8% support
IDEXX Laboratories, Inc.2026-05-12Amend Certificate of Incorporation to Provide Shareholders Owning 25% of the Shares of our Capital Stock the Right to Have IDEXX Call a Special Meeting (Proposal Five).AbstainFOR — 26 of 27 Vanguard fundsAgainst—
Roblox Corporation2026-05-28Election of Class II Directors: David BaszuckiWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 93.9% support
Roblox Corporation2026-05-28Election of Class II Directors: Gregory BaszuckiWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 93.7% support
Unity Software Inc.2026-05-13To elect each of the Board of Directors' three nominees for director named in the accompanying proxy statement, to serve as a Class III member of the Board of Directors until the 2029 Annual Meeting of Stockholders and until their successors are elected and qualified, subject to their earlier death,WithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 79.3% support
First Solar, Inc.2026-05-13Shareholder Stockholder proposal to improve shareholder ability to call for a special shareholder meetingForAGAINST — 27 of 28 Vanguard fundsAgainstNot approved, 43.2% support
Ball Corporation2026-04-29Election of Directors: Todd A. PenegorForAGAINST — 17 of 17 Vanguard fundsForPassed (calculated), 60.3% support
Crown Holdings, Inc.2026-04-30Shareholder Consideration of a Shareholder proposal regarding Shareholder right to act by written consent.ForAGAINST — 18 of 18 Vanguard fundsAgainst—
Match Group, Inc.2026-06-16To approve a non-binding advisory resolution on executive compensation.AgainstFOR — 27 of 28 Vanguard fundsAgainstNot approved, 42.8% support
Elastic N.V.2025-09-30Appointment of the following executive director and non-executive director, respectively, each for a term of three (3) years, ending at the close of the Annual General Meeting of 2028: Ashutosh KulkarniAgainstFOR — 17 of 17 Vanguard fundsAgainstPassed (calculated), 72.0% support
Elastic N.V.2025-09-30Appointment of the following executive director and non-executive director, respectively, each for a term of three (3) years, ending at the close of the Annual General Meeting of 2028: Steven SchuurmanAgainstFOR — 17 of 17 Vanguard fundsAgainstPassed (calculated), 64.7% support
Molson Coors Beverage Company2026-05-06Election of Directors: Roger G. EatonForWITHHOLD — 18 of 18 Vanguard fundsForPassed (calculated), 66.3% support
Zillow Group, Inc.2026-06-02Election of Directors: Amy C. BohutinskyAgainstFOR — 17 of 17 Vanguard fundsAgainstPassed (calculated), 93.2% support
Zillow Group, Inc.2026-06-02Election of Directors: Jay C. HoagAgainstFOR — 17 of 17 Vanguard fundsAgainstPassed (calculated), 94.7% support
Pilgrim's Pride Corporation2026-04-29Shareholder A stockholder proposal to provide a political spending disclosure.ForAGAINST — 18 of 18 Vanguard fundsAgainstNot approved, 6.3% support
Pilgrim's Pride Corporation2026-04-29Election of Directors: JBS Directors: Joanita KaroleskiWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 94.6% support
Pilgrim's Pride Corporation2026-04-29Election of Directors: JBS Directors: Joesley Mendonca BatistaWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 92.0% support
Pilgrim's Pride Corporation2026-04-29Election of Directors: JBS Directors: Wesley Mendonca Batista FilhoWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 94.5% support
Enact Holdings, Inc.2026-05-13Election of Directors: Thomas J. McInerneyWithholdFOR — 18 of 18 Vanguard fundsAgainstPassed (calculated), 92.6% support
Vishay Intertechnology, Inc.2026-05-183 wordings Election of Directors Nominees for 3-year terms: Michael J. CodyWithholdFOR — 17 of 17 Vanguard fundsAgainst—
Resideo Technologies, Inc.2026-06-03Shareholder Shareholder Proposal Regarding Shareholder Right to Act by Written Consent.ForAGAINST — 18 of 18 Vanguard fundsAgainstNot approved, 23.7% support
Peloton Interactive, Inc.2025-12-09Election of Directors: Chris BruzzoWithholdFOR — 17 of 17 Vanguard fundsAgainstElected, 77.8% support
Concentrix Corporation2026-03-25Approval of an amendment to the Company's 2020 Stock Incentive Plan to increase the number of shares available for issuance.AgainstFOR — 17 of 17 Vanguard fundsAgainstApproved, 69.8% support
Worthington Steel, Inc.2025-09-24Elect three directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: Jon J. BowsherAgainstFOR — 17 of 17 Vanguard fundsAgainstPassed (calculated), 85.1% support
Worthington Steel, Inc.2025-09-24Elect three directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: Mary SchiavoAgainstFOR — 17 of 17 Vanguard fundsAgainstPassed (calculated), 78.3% support
Ultragenyx Pharmaceutical Inc.2026-05-14Approval of the Third Amended and Restated 2023 Incentive Plan.AgainstFOR — 17 of 17 Vanguard fundsAgainstApproved, 68.9% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: David HodgsonWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 60.8% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: Jacqueline KosecoffWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 76.1% support
Alignment Healthcare, Inc.2026-06-04Election of Directors: Jody BilneyWithholdFOR — 18 of 18 Vanguard fundsAgainstElected, 76.1% support
Select Medical Holdings Corporation2026-04-23Shareholder Non-Binding Advisory Vote on a Stockholder Proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold, if properly presented at the meeting.ForAGAINST — 18 of 18 Vanguard fundsAgainstFailed (calculated), 20.0% support
Select Medical Holdings Corporation2026-04-23Non-Binding Advisory Vote on a Company Proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold.AgainstFOR — 18 of 18 Vanguard fundsAgainst—
AppLovin Corporation2026-06-03Approval of an amendment to our amended and restated certificate of incorporation to provide for officer exculpation as permitted by Delaware law.AgainstFOR — 25 of 26 Vanguard fundsAgainstApproved, 90.1% support
Comcast Corporation2026-06-10Shareholder Adopt policy to have an independent chairForAGAINST — 25 of 26 Vanguard fundsAgainstNot approved, 26.4% support
FedEx Corporation2025-09-29Advisory vote to approve named executive officer compensation.AgainstFOR — 33 of 35 Vanguard fundsAgainstApproved, 63.4% support
PPG Industries, Inc.2026-04-16Shareholder Shareholder proposal to adopt a policy requiring an independent board chair, if properly presentedForAGAINST — 25 of 26 Vanguard fundsAgainstNot approved, 32.0% support
Incyte Corporation2026-06-08Election of Directors to serve until the 2027 annual meeting of shareholders and thereafter until their successors are duly elected and qualified: Julian C. BakerAgainstFOR — 25 of 26 Vanguard fundsAgainstElected, 80.9% support
Unity Software Inc.2026-05-13To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement.AgainstFOR — 25 of 26 Vanguard fundsAgainstApproved, 72.2% support
Toast, Inc.2026-06-12Election of Directors: Kent BennettWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 91.3% support
Toast, Inc.2026-06-12Election of Directors: Susan Chapman-HughesWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 93.5% support
BridgeBio Pharma, Inc.2026-06-22To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares.AgainstFOR — 16 of 16 Vanguard fundsAgainstApproved, 82.9% support
The AES Corporation2026-04-29Shareholder If properly presented, to vote on a non-binding stockholder proposal regarding stockholder ability to call a special meeting.ForAGAINST — 16 of 16 Vanguard fundsAgainstFailed (calculated), 34.8% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Kenneth HobermanWithholdFOR — 16 of 16 Vanguard fundsAgainstPassed (calculated), 65.5% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Laurence CharneyWithholdFOR — 16 of 16 Vanguard fundsAgainstPassed (calculated), 83.7% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Michael S. WeissWithholdFOR — 16 of 16 Vanguard fundsAgainstPassed (calculated), 88.6% support
CVR Energy, Inc.2026-06-04To elect ten directors for terms of one year each, to serve until their successors have been duly elected and qualified: Brett IcahnWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 92.6% support
CVR Energy, Inc.2026-06-04To elect ten directors for terms of one year each, to serve until their successors have been duly elected and qualified: David L. LampWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 92.6% support
CVR Energy, Inc.2026-06-04To elect ten directors for terms of one year each, to serve until their successors have been duly elected and qualified: Julia Heidenreich VolivaForWITHHOLD — 16 of 16 Vanguard fundsForElected, 93.9% support
CVR Energy, Inc.2026-06-04To elect ten directors for terms of one year each, to serve until their successors have been duly elected and qualified: Mark A. PytoshWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 93.1% support
CVR Energy, Inc.2026-06-04To elect ten directors for terms of one year each, to serve until their successors have been duly elected and qualified: Robert E. FlintWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 92.5% support
CVR Energy, Inc.2026-06-04To elect ten directors for terms of one year each, to serve until their successors have been duly elected and qualified: Stephen MongilloForWITHHOLD — 16 of 16 Vanguard fundsForElected, 88.3% support
Appian Corporation2026-06-03Election of Directors: Barbara Bobbie KilbergWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 96.2% support
Appian Corporation2026-06-03Election of Directors: Mark LynchWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 98.4% support
Appian Corporation2026-06-03Election of Directors: Matthew CalkinsWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 98.2% support
Appian Corporation2026-06-03Election of Directors: Michael BeckleyWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 98.3% support
Appian Corporation2026-06-03Election of Directors: Robert C. KramerWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 98.3% support
Appian Corporation2026-06-03Election of Directors: Shirley A. EdwardsWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 98.0% support
Asana, Inc.2026-06-08Election of three Class III directors to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Krista Anderson-CoppermanWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 92.8% support
Asana, Inc.2026-06-08Election of three Class III directors to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Sydney CareyWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 93.6% support
The Boston Beer Company, Inc.2026-05-27Advisory vote to approve our Named Executive Officers' executive compensation.AgainstFOR — 25 of 26 Vanguard fundsAgainst—
Capri Holdings Limited2025-08-07To approve the Capri Holdings Limited Fourth Amended and Restated Omnibus Incentive Plan.AgainstFOR — 16 of 16 Vanguard fundsAgainstApproved, 74.8% support
Arlo Technologies, Inc.2026-06-18Election of three Class II directors for three-year terms: Amy RothsteinWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 81.0% support
Arlo Technologies, Inc.2026-06-18Election of three Class II directors for three-year terms: Prashant (Sean) AggarwalWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 80.8% support
Innovative Industrial Properties, Inc.2026-06-09Approval of the adoption of the Innovative Industrial Properties, Inc. 2026 Omnibus Incentive Plan.AgainstFOR — 16 of 16 Vanguard fundsAgainstPassed (calculated), 79.3% support
Verra Mobility Corporation2026-05-19Elect three Class II directors, Patrick J. Byrne, David M. Roberts, and John H. Rexford, to serve on our Board until our 2029 Annual Meeting of Stockholders: John H. RexfordWithholdFOR — 16 of 16 Vanguard fundsAgainstElected, 66.7% support
SoFi Technologies, Inc.2026-06-17Election of Directors: Tom HuttonWithholdFOR — 15 of 15 Vanguard fundsAgainstElected, 82.1% support
Guardant Health, Inc.2026-06-17Election of Class II Directors: Ian ClarkWithholdFOR — 15 of 15 Vanguard fundsAgainstElected, 65.0% support
Guardant Health, Inc.2026-06-17Election of Class II Directors: Manuel Hidalgo MedinaWithholdFOR — 15 of 15 Vanguard fundsAgainstElected, 75.5% support
BridgeBio Pharma, Inc.2026-06-22To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly eleWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 80.1% support
Trimble Inc.2026-05-26Election of Directors: Mark S. PeekWithholdFOR — 24 of 25 Vanguard fundsAgainst—
Murphy USA Inc.2026-05-07Shareholder Stockholder Proposal - Give Shareholders the Ability to Call for a Special Shareholder Meeting.ForAGAINST — 15 of 15 Vanguard fundsAgainstNot approved, 34.0% support
Clear Secure, Inc.2026-06-10Approval of, on an advisory basis, the compensation of our named executive officers.AgainstFOR — 24 of 25 Vanguard fundsAgainstApproved, 95.4% support
Axsome Therapeutics, Inc.2026-06-05Election of Directors: Mark SaadWithholdFOR — 15 of 15 Vanguard fundsAgainstElected, 73.6% support
Axsome Therapeutics, Inc.2026-06-05Election of Directors: Susan Mahony, Ph.D., MBAWithholdFOR — 15 of 15 Vanguard fundsAgainstElected, 76.7% support
Clearway Energy, Inc.2026-04-29Election of Directors: Brian R. FordWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 88.9% support
Clearway Energy, Inc.2026-04-29Election of Directors: Bruce MacLennanWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 88.6% support
Clearway Energy, Inc.2026-04-29Election of Directors: Craig CorneliusWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 89.3% support
Clearway Energy, Inc.2026-04-29Election of Directors: Daniel B. MoreWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 82.8% support
Clearway Energy, Inc.2026-04-29Election of Directors: Jennifer LowryWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 89.6% support
Clearway Energy, Inc.2026-04-29Election of Directors: Jonathan BramWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 86.3% support
Clearway Energy, Inc.2026-04-29Election of Directors: Marc-Antoine PignonWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 88.5% support
Clearway Energy, Inc.2026-04-29Election of Directors: Nathaniel AnschuetzWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 88.6% support
Clearway Energy, Inc.2026-04-29Election of Directors: Olivier JounyWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 85.3% support
Clearway Energy, Inc.2026-04-29Election of Directors: Paige GoodwinWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 88.7% support
Cogent Biosciences, Inc.2026-06-09Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Arlene M. MorrisWithholdFOR — 15 of 15 Vanguard fundsAgainstElected, 83.9% support
Cogent Biosciences, Inc.2026-06-09Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Chris CainWithholdFOR — 15 of 15 Vanguard fundsAgainstElected, 86.8% support
Cogent Biosciences, Inc.2026-06-09Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Todd ShegogWithholdFOR — 15 of 15 Vanguard fundsAgainstElected, 86.7% support
Nelnet, Inc.2026-05-14Election of three Class III directors for three-year terms: Kathleen A. FarrellAgainstFOR — 15 of 15 Vanguard fundsAgainstElected, 96.7% support
United Natural Foods, Inc.2025-12-16The approval of the Fifth Amended and Restated 2020 Equity Incentive Plan.AgainstFOR — 15 of 15 Vanguard fundsAgainstApproved, 72.5% support
Ambarella, Inc.2026-06-26To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan.AgainstFOR — 15 of 15 Vanguard fundsAgainst—
IDT Corporation2025-12-11Election of Directors: Elaine S. YatzkanAgainstFOR — 15 of 15 Vanguard fundsAgainstElected, 91.4% support
IDT Corporation2025-12-11Election of Directors: Howard S. JonasAgainstFOR — 15 of 15 Vanguard fundsAgainstElected, 89.8% support
Corsair Gaming, Inc.2026-06-16Election of two Class II Directors to serve until the 2029 annual meeting of stockholders or until their successors are elected: Randall J. WeisenburgerWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 85.7% support
Corsair Gaming, Inc.2026-06-16Election of two Class II Directors to serve until the 2029 annual meeting of stockholders or until their successors are elected: Thi LaWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 91.4% support
PagerDuty, Inc.2026-06-18To elect four Class I directors for terms expiring at our 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Donald CartyWithholdFOR — 15 of 15 Vanguard fundsAgainstElected, 78.2% support
PagerDuty, Inc.2026-06-18To elect four Class I directors for terms expiring at our 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Jennifer TejadaWithholdFOR — 15 of 15 Vanguard fundsAgainstElected, 71.2% support
PagerDuty, Inc.2026-06-18To elect four Class I directors for terms expiring at our 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Sarah FranklinWithholdFOR — 15 of 15 Vanguard fundsAgainstElected, 71.3% support
PagerDuty, Inc.2026-06-18To elect four Class I directors for terms expiring at our 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: William LoschWithholdFOR — 15 of 15 Vanguard fundsAgainstElected, 69.7% support
Rapid7, Inc.2026-06-09Election of Directors: Jeff KalowskiWithholdFOR — 15 of 15 Vanguard fundsAgainstPassed (calculated), 53.7% support
AbbVie Inc.2026-05-08Shareholder Stockholder Proposal - to Adopt a Policy to Require an Independent ChairForAGAINST — 29 of 31 Vanguard fundsAgainstNot approved, 39.6% support
NextEra Energy, Inc.2026-05-21Shareholder A proposal entitled "Paris Agreement Alignment" requesting NextEra Energy publish a report describing if and how the Company plans to reduce its total contribution to climate change and align its operations and investments with the Paris Agreement's goal of maintaining global temperatures well belowForAGAINST — 22 of 23 Vanguard fundsAgainstNot approved, 34.6% support
Deere & Company2026-02-25Shareholder Shareholder proposal on shareholder right to act by written consentForAGAINST — 28 of 30 Vanguard fundsAgainstNot approved, 38.5% support
Comcast Corporation2026-06-10Advisory vote on executive compensationAgainstFOR — 28 of 30 Vanguard fundsAgainstApproved, 58.4% support
Humana Inc.2026-04-16Shareholder The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting.ForAGAINST — 28 of 30 Vanguard fundsAgainstNot approved, 41.5% support
The Hartford Insurance Group, Inc.2026-05-20Shareholder Shareholder proposal that the Company adopt written consent rights for shareholdersForAGAINST — 28 of 30 Vanguard fundsAgainstNot approved, 45.2% support
Verisk Analytics, Inc.2026-05-19Shareholder Shareholder Proposal - Shareholder Right to Act by Written Consent.ForAGAINST — 22 of 23 Vanguard fundsAgainstApproved, 53.3% support
Micron Technology, Inc.2026-01-15Shareholder SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT.ForAGAINST — 27 of 29 Vanguard fundsAgainstNot approved, 43.0% support
Analog Devices, Inc.2026-03-11Shareholder To consider a shareholder proposal, if properly presented at the Annual Meeting.ForAGAINST — 27 of 29 Vanguard fundsAgainst—
Booking Holdings Inc.2026-06-02Shareholder Non-binding stockholder vote on a proposal to avoid brand damage due to corporate political spending.ForAGAINST — 21 of 22 Vanguard fundsAgainstNot approved, 35.2% support
NXP Semiconductors N.V.2026-06-10Appoint Anthony Foxx as non-executive directorAgainstFOR — 14 of 14 Vanguard fundsAgainstPassed (calculated), 94.2% support
Autodesk, Inc.2026-06-17Shareholder Stockholder proposal requesting amendment to stockholder special meeting right.ForAGAINST — 27 of 29 Vanguard fundsAgainstFailed (calculated), 47.6% support
Circle Internet Group, Inc.2026-05-14Election of Three Class I Directors: P. Sean NevilleAgainstFOR — 14 of 14 Vanguard fundsAgainstElected, 89.6% support
ViaSat, Inc.2025-09-04Amendment and Restatement of the 1996 Equity Participation PlanAgainstFOR — 14 of 14 Vanguard fundsAgainstPassed (calculated), 78.0% support
The Vita Coco Company, Inc.2026-06-03Election of Class II Directors: Kenneth SadowskyWithholdFOR — 14 of 14 Vanguard fundsAgainstPassed (calculated), 80.8% support
United States Lime & Minerals, Inc.2026-05-01To elect Directors - Nominees: A. M. DoumetWithholdFOR — 14 of 14 Vanguard fundsAgainstElected, 87.9% support
Rigetti Computing, Inc.2026-06-09To elect one Class I director to hold office until the 2029 Annual Meeting of Stockholders: Dr. Subodh KulkarniWithholdFOR — 14 of 14 Vanguard fundsAgainstPassed (calculated), 89.5% support
Customers Bancorp, Inc.2026-05-26To approve an amendment to the Company's 2019 Stock Incentive Plan.AgainstFOR — 14 of 14 Vanguard fundsAgainstPassed (calculated), 69.8% support
F&G Annuities & Life, Inc.2026-06-24Election of three Class I directors to serve until the 2029 annual meeting of shareholders: John D. RoodWithholdFOR — 14 of 14 Vanguard fundsAgainstPassed (calculated), 92.2% support
F&G Annuities & Life, Inc.2026-06-24Election of three Class I directors to serve until the 2029 annual meeting of shareholders: Michael J. NolanWithholdFOR — 14 of 14 Vanguard fundsAgainstPassed (calculated), 92.8% support
Walker & Dunlop, Inc.2026-05-19Advisory resolution to approve executive compensationAgainstFOR — 21 of 22 Vanguard fundsAgainstPassed (calculated), 70.9% support
Alight, Inc.2026-06-10To elect three Class II director nominees named in the proxy statement to our Board of Directors (the "Board"): Richard N. MasseyWithholdFOR — 14 of 14 Vanguard fundsAgainstPassed (calculated), 68.9% support
Alight, Inc.2026-06-10To elect three Class II director nominees named in the proxy statement to our Board of Directors (the "Board"): Robert A. Lopes, Jr.WithholdFOR — 14 of 14 Vanguard fundsAgainstPassed (calculated), 78.3% support
HCA Healthcare, Inc.2026-04-23Shareholder Stockholder proposal, if properly presented at the meeting, regarding stockholders' right to act by written consent.ForAGAINST — 25 of 27 Vanguard fundsAgainstNot approved, 22.0% support
MongoDB, Inc.2026-06-30Election of three Class III directors, each to serve until our Annual Meeting of Stockholders in 2029: Archana AgrawalWithholdFOR — 20 of 21 Vanguard fundsAgainstPassed (calculated), 78.6% support
MongoDB, Inc.2026-06-30Election of three Class III directors, each to serve until our Annual Meeting of Stockholders in 2029: Dwight MerrimanWithholdFOR — 20 of 21 Vanguard fundsAgainstElected, 80.4% support
MongoDB, Inc.2026-06-30Election of three Class III directors, each to serve until our Annual Meeting of Stockholders in 2029: Hope CochranWithholdFOR — 20 of 21 Vanguard fundsAgainstElected, 72.5% support
Medpace Holdings, Inc.2026-05-15Shareholder Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting.ForAGAINST — 20 of 21 Vanguard fundsAgainstFailed (calculated), 34.1% support
Ally Financial Inc.2026-05-06Shareholder Shareholder Proposal to Reduce Threshold for Shareholders to Call Special Meetings.ForAGAINST — 20 of 21 Vanguard fundsAgainstFailed (calculated), 29.4% support
Summit Therapeutics Inc.2026-06-10ELECTION OF DIRECTORS: Kenneth A. ClarkWithholdFOR — 13 of 13 Vanguard fundsAgainstPassed (calculated), 96.1% support
Summit Therapeutics Inc.2026-06-10ELECTION OF DIRECTORS: Mahkam ZanganehWithholdFOR — 13 of 13 Vanguard fundsAgainstPassed (calculated), 98.5% support
Summit Therapeutics Inc.2026-06-10ELECTION OF DIRECTORS: Manmeet S. SoniWithholdFOR — 13 of 13 Vanguard fundsAgainstPassed (calculated), 98.4% support
Summit Therapeutics Inc.2026-06-10ELECTION OF DIRECTORS: Robert W. DugganWithholdFOR — 13 of 13 Vanguard fundsAgainstPassed (calculated), 98.3% support
Summit Therapeutics Inc.2026-06-10ELECTION OF DIRECTORS: Yu (Michelle) XiaWithholdFOR — 13 of 13 Vanguard fundsAgainstPassed (calculated), 98.3% support
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: J. Kristofer GalashanWithholdFOR — 13 of 13 Vanguard fundsAgainstElected, 76.4% support
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: Jennifer PomerantzWithholdFOR — 13 of 13 Vanguard fundsAgainstElected, 77.4% support
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: Jonathan CosletWithholdFOR — 13 of 13 Vanguard fundsAgainstElected, 79.6% support
CVR Energy, Inc.2026-06-04To approve, on an advisory basis, our named executive officer compensation.AgainstFOR — 20 of 21 Vanguard fundsAgainstApproved, 91.6% support
AvePoint, Inc.2026-05-05Election of Directors: Jeff EpsteinWithholdFOR — 13 of 13 Vanguard fundsAgainstPassed (calculated), 76.8% support
Arcutis Biotherapeutics, Inc.2026-06-053 wordings Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Patrick J. HeronWithholdFOR — 13 of 13 Vanguard fundsAgainstPassed (calculated), 67.4% support
Intapp, Inc.2025-11-18To elect three Class II Directors, each to hold office until our Annual Meeting of Stockholders in 2028 and until her successor is duly elected and qualified: Beverly AllenWithholdFOR — 13 of 13 Vanguard fundsAgainstElected, 81.0% support
Intapp, Inc.2025-11-18To elect three Class II Directors, each to hold office until our Annual Meeting of Stockholders in 2028 and until her successor is duly elected and qualified: Marie WieckWithholdFOR — 13 of 13 Vanguard fundsAgainstElected, 66.2% support
Rush Street Interactive, Inc.2026-06-03Approval of amendments to the Charter to (a) provide for officer exculpation as permitted by Delaware law, and (b) make certain clarifying changes to the director removal process.AgainstFOR — 13 of 13 Vanguard fundsAgainstPassed (calculated), 78.8% support
Asana, Inc.2026-06-08Approval, on an advisory basis, of the compensation of the Company's named executive officers ("Say-on-Pay").AgainstFOR — 20 of 21 Vanguard fundsAgainstApproved, 94.7% support
Fastly, Inc.2026-06-03To elect each of the Board's three nominees for director named in the accompanying proxy statement, to serve as a Class I member of the Board of Directors until the 2029 annual meeting of stockholders: Aida AlvarezWithholdFOR — 13 of 13 Vanguard fundsAgainstPassed (calculated), 65.1% support
Innovative Industrial Properties, Inc.2026-06-09Approval on a non-binding advisory basis of the compensation of the Company's named executive officers.AgainstFOR — 20 of 21 Vanguard fundsAgainstPassed (calculated), 63.9% support
Syndax Pharmaceuticals, Inc.2026-06-10Election of Directors: Pierre LegaultWithholdFOR — 13 of 13 Vanguard fundsAgainstPassed (calculated), 63.5% support
Arvinas, Inc.2026-06-24Election of two Class II directors: Leslie V. Norwalk, Esq.WithholdFOR — 13 of 13 Vanguard fundsAgainstPassed (calculated), 75.8% support
QUALCOMM Incorporated2026-03-17Shareholder Stockholder proposal entitled "Shareholder Ability to Call for a Special Meeting."ForAGAINST — 34 of 38 Vanguard fundsAgainstNot approved, 42.2% support
Uber Technologies, Inc.2026-05-04Election of Directors: Nikesh AroraAgainstFOR — 24 of 26 Vanguard fundsAgainstElected, 79.7% support
Cloudflare, Inc.2026-06-30Approval of the amendment and restatement of our Amended and Restated 2019 Employee Stock Purchase Plan.AgainstFOR — 19 of 20 Vanguard fundsAgainstApproved, 71.6% support
Cloudflare, Inc.2026-06-30Approval, on an advisory basis, of the compensation of our named executive officers.AgainstFOR — 24 of 26 Vanguard fundsAgainstApproved, 76.2% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSciWithholdFOR — 12 of 12 Vanguard fundsAgainstElected, 85.3% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William FaireyWithholdFOR — 12 of 12 Vanguard fundsAgainstElected, 86.8% support
Mirum Pharmaceuticals, Inc.2026-06-15To elect the Board's three Class III nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Timothy WalbertWithholdFOR — 12 of 12 Vanguard fundsAgainstElected, 69.7% support
Remitly Global, Inc.2026-06-10Election of Directors: Nigel MorrisWithholdFOR — 12 of 12 Vanguard fundsAgainstElected, 68.9% support
Madison Square Garden Entertainment Corp.2025-12-10Election of the following nominees as directors: Donna M. ColemanWithholdFOR — 12 of 12 Vanguard fundsAgainstElected, 79.5% support
Madison Square Garden Entertainment Corp.2025-12-10Election of the following nominees as directors: Frederic V. SalernoWithholdFOR — 12 of 12 Vanguard fundsAgainstElected, 79.6% support
Madison Square Garden Entertainment Corp.2025-12-10Election of the following nominees as directors: Martin BandierWithholdFOR — 12 of 12 Vanguard fundsAgainstElected, 79.4% support
Xeris Biopharma Holdings, Inc.2026-06-04To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Dawn HalkuffWithholdFOR — 12 of 12 Vanguard fundsAgainstElected, 71.5% support
Xeris Biopharma Holdings, Inc.2026-06-04To elect two Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: John JohnsonWithholdFOR — 12 of 12 Vanguard fundsAgainstElected, 60.2% support
Puma Biotechnology, Inc.2026-06-11Approve an amendment to extend the expiration date until October 4, 2028 of a warrant held by Alan H. Auerbach, as described in the proxy statement.AgainstFOR — 12 of 12 Vanguard fundsAgainstPassed (calculated), 97.9% support
James River Group Holdings, Ltd.2025-10-23To approve, on a non-binding, advisory basis, the 2024 compensation of our named executive officers.AgainstFOR — 12 of 12 Vanguard fundsAgainstPassed (calculated), 63.4% support
Select Medical Holdings Corporation2026-06-26To consider and vote on the proposal to approve, on a non-binding, advisory basis, the compensation that will or may become payable by the Company to its named executive officers in connection with the Merger (the "Compensation Proposal").AgainstFOR — 19 of 20 Vanguard fundsAgainstPassed (calculated), 51.9% support
AppLovin Corporation2026-06-03Shareholder Stockholder proposal regarding disclosure of voting results by class of shares, if properly presented at the meeting.ForAGAINST — 23 of 25 Vanguard fundsAgainstNot approved, 14.6% support
American International Group, Inc.2026-05-13Advisory Vote to Approve Named Executive Officer Compensation.AgainstFOR — 32 of 36 Vanguard fundsForPassed (calculated), 77.5% support
Fidelity National Information Services, Inc.2026-06-10To approve, on an advisory basis, the compensation of the Company's named executive officers.AgainstFOR — 28 of 31 Vanguard fundsAgainstApproved, 70.6% support
Customers Bancorp, Inc.2026-05-26To approve a non-binding advisory resolution on named executive officer compensation.AgainstFOR — 18 of 19 Vanguard fundsAgainstPassed (calculated), 67.9% support
Coupang, Inc.2026-06-11Election of Directors: Ambereen ToubassyAgainstFOR — 11 of 11 Vanguard fundsAgainstElected, 96.7% support
Coupang, Inc.2026-06-11Election of Directors: Bom KimAgainstFOR — 11 of 11 Vanguard fundsAgainstElected, 97.8% support
Coupang, Inc.2026-06-11Election of Directors: Jason ChildAgainstFOR — 11 of 11 Vanguard fundsAgainstElected, 97.1% support
Dover Corporation2026-05-08Shareholder To consider a shareholder proposal requesting an independent board chair.ForAGAINST — 22 of 24 Vanguard fundsAgainstFailed (calculated), 36.0% support
James Hardie Industries Plc2025-10-29Approve Grant of Return on Capital Employed Restricted Stock Units to Aaron ErterAgainstFOR — 11 of 11 Vanguard fundsAgainst—
James Hardie Industries Plc2025-10-29Approve Increase in Non-Executive Director Fee PoolAgainstFOR — 11 of 11 Vanguard funds——
James Hardie Industries Plc2025-10-29Approve the Remuneration ReportAgainstFOR — 11 of 11 Vanguard fundsAgainst—
James Hardie Industries Plc2025-10-29Elect Anne Lloyd as DirectorAgainstFOR — 11 of 11 Vanguard fundsAgainst—
James Hardie Industries Plc2025-10-29Elect Gary Hendrickson as DirectorAgainstFOR — 11 of 11 Vanguard fundsAgainst—
James Hardie Industries Plc2025-10-29Elect Howard Heckes as DirectorAgainstFOR — 11 of 11 Vanguard fundsAgainst—
James Hardie Industries Plc2025-10-29Elect Peter John Davis as DirectorAgainstFOR — 11 of 11 Vanguard fundsAgainst—
James Hardie Industries Plc2025-10-29Elect Rada Rodriguez as DirectorAgainstFOR — 11 of 11 Vanguard fundsAgainst—
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen IIIWithholdFOR — 11 of 11 Vanguard fundsAgainstPassed (calculated), 96.9% support
Biohaven Ltd.2026-04-28Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Irina Antonijevic, M.D., Ph.D.AgainstFOR — 11 of 11 Vanguard fundsAgainstElected, 84.0% support
Biohaven Ltd.2026-04-28Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. HeffernanAgainstFOR — 11 of 11 Vanguard fundsAgainstElected, 83.5% support
Biohaven Ltd.2026-04-28Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Robert J. HuginAgainstFOR — 11 of 11 Vanguard fundsAgainstElected, 84.0% support
Fluence Energy, Inc.2026-03-12To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Axel MeierWithholdFOR — 11 of 11 Vanguard fundsAgainstPassed (calculated), 94.1% support
Fluence Energy, Inc.2026-03-12To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Fahad Al-DarwishWithholdFOR — 11 of 11 Vanguard fundsAgainstPassed (calculated), 95.8% support
Fluence Energy, Inc.2026-03-12To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Herman BullsWithholdFOR — 11 of 11 Vanguard fundsAgainstPassed (calculated), 95.0% support
Fluence Energy, Inc.2026-03-12To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: John Christopher ("Chris") SheltonWithholdFOR — 11 of 11 Vanguard fundsAgainst—
Fluence Energy, Inc.2026-03-12To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Julian NebredaWithholdFOR — 11 of 11 Vanguard fundsAgainst—
Fluence Energy, Inc.2026-03-12To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Letitia ("Tish") MendozaWithholdFOR — 11 of 11 Vanguard fundsAgainstPassed (calculated), 94.1% support
Fluence Energy, Inc.2026-03-12To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Peter Chi-Shun LukWithholdFOR — 11 of 11 Vanguard fundsAgainstPassed (calculated), 95.8% support
Fluence Energy, Inc.2026-03-12To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Ruth GratzkeWithholdFOR — 11 of 11 Vanguard fundsAgainstPassed (calculated), 94.1% support
8x8, Inc.2025-07-25To approve an amendment to the 8x8, Inc.'s 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 8,500,000 shares.AgainstFOR — 11 of 11 Vanguard fundsAgainstApproved, 62.2% support
Alector, Inc.2026-06-17ELECTION OF DIRECTORS: Kristine Yaffe, M.D.WithholdFOR — 11 of 11 Vanguard fundsAgainstPassed (calculated), 74.8% support
PrimeEnergy Resources Corporation2026-06-10Election of Directors: Beverly A. CummingsWithholdFOR — 11 of 11 Vanguard fundsAgainstElected, 77.2% support
PrimeEnergy Resources Corporation2026-06-10Election of Directors: Charles E. Drimal, Jr.WithholdFOR — 11 of 11 Vanguard fundsAgainstElected, 84.2% support
Nu Skin Enterprises, Inc.2026-05-28Approval of our Amended and Restated 2024 Omnibus Incentive PlanAgainstFOR — 11 of 11 Vanguard fundsAgainstPassed (calculated), 70.4% support
Netflix, Inc.2026-06-04Shareholder Stockholder proposal entitled, "Proposal 4 - Shareholder Right to Act by Written Consent," if properly presented at the meeting.ForAGAINST — 25 of 28 Vanguard fundsAgainstNot approved, 44.6% support
Wells Fargo & Company2026-04-28Shareholder Shareholder Proposal - Request for Board of Directors to Adopt Policy for an Independent Chair.ForAGAINST — 33 of 38 Vanguard fundsAgainstFailed (calculated), 34.3% support
Vertex Pharmaceuticals Incorporated2026-05-13Shareholder Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent.ForAGAINST — 21 of 23 Vanguard fundsAgainstApproved, 57.0% support
Meritage Homes Corporation2026-05-21Shareholder Shareholder proposal to improve shareholder ability to call for a special shareholder meeting.ForAGAINST — 16 of 17 Vanguard fundsAgainstNot approved, 25.6% support
Graphic Packaging Holding Company2026-06-11Shareholder Stockholder Proposal - Give Shareholders the Ability to call for a Special Shareholder Meeting.ForAGAINST — 16 of 17 Vanguard fundsAgainstFailed (calculated), 42.2% support
Enviri Corporation2026-05-04Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to our named executive officers in connection with the transactions contemplated by the Merger Agreement and the Separation Agreement.AgainstFOR — 16 of 17 Vanguard fundsAgainst—
Regions Financial Corporation2026-05-06Shareholder Shareholder Proposal Relating to Special Shareholder Meeting.ForAGAINST — 24 of 27 Vanguard fundsAgainstNot approved, 43.9% support
CNA Financial Corporation2026-04-29Election to the Board of the ten nominees named below: Andre RiceForWITHHOLD — 10 of 10 Vanguard fundsForElected, 99.5% support
CNA Financial Corporation2026-04-29Election to the Board of the ten nominees named below: Don M. RandelForWITHHOLD — 10 of 10 Vanguard fundsForElected, 99.3% support
CNA Financial Corporation2026-04-29Election to the Board of the ten nominees named below: Jose O. MontemayorForWITHHOLD — 10 of 10 Vanguard fundsForElected, 99.1% support
CNA Financial Corporation2026-04-29Election to the Board of the ten nominees named below: Michael A. BlessForWITHHOLD — 10 of 10 Vanguard fundsForElected, 99.2% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Daniel HumeWithholdFOR — 15 of 16 Vanguard fundsAgainstPassed (calculated), 78.6% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Sagar Lonial, MDWithholdFOR — 15 of 16 Vanguard fundsAgainstPassed (calculated), 54.9% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Yann EchelardWithholdFOR — 15 of 16 Vanguard fundsAgainstPassed (calculated), 78.7% support
Centuri Holdings, Inc.2026-05-19Election of Directors: Anne L. MariucciWithholdFOR — 10 of 10 Vanguard fundsAgainstPassed (calculated), 79.5% support
Taysha Gene Therapies, Inc.2026-06-01To elect the Board's Class III Director nominees, Sean P. Nolan and Laura Sepp-Lorenzino, Ph.D. to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Laura Sepp-Lorenzino, Ph.D.WithholdFOR — 10 of 10 Vanguard fundsAgainstElected, 73.3% support
Taysha Gene Therapies, Inc.2026-06-01To elect the Board's Class III Director nominees, Sean P. Nolan and Laura Sepp-Lorenzino, Ph.D. to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Sean P. NolanWithholdFOR — 10 of 10 Vanguard fundsAgainstElected, 82.6% support
Ameresco, Inc.2026-06-04Elect two (2) directors to the Ameresco, Inc. Board of Directors for a three-year term or until their successors are elected and qualified: Claire Hughes-JohnsonWithholdFOR — 10 of 10 Vanguard fundsAgainstPassed (calculated), 90.8% support
Ameresco, Inc.2026-06-04Elect two (2) directors to the Ameresco, Inc. Board of Directors for a three-year term or until their successors are elected and qualified: Frank V. WisneskiWithholdFOR — 10 of 10 Vanguard fundsAgainstPassed (calculated), 86.8% support
Ameresco, Inc.2026-06-04To approve an amendment to Ameresco's 2020 Stock Incentive Plan ("Plan) to increase the number of shares of Ameresco, Inc. Class A Common Stock authorized for issuance under the Plan by 3,200,000 from 5,000,000 to 8,200,000 as described in the Ameresco, Inc. Proxy Statement.AgainstFOR — 10 of 10 Vanguard fundsAgainstPassed (calculated), 89.3% support
CEVA, Inc.2026-06-02Advisory vote to approve named executive officer compensationAgainstFOR — 15 of 16 Vanguard fundsAgainstApproved, 50.2% support
Scholastic Corporation2025-09-17Election of Directors: James W. BargeWithholdFOR — 10 of 10 Vanguard fundsAgainstPassed (calculated), 53.5% support
Camping World Holdings, Inc.2026-05-21Election of Class I Directors: K. Dillon SchickliWithholdFOR — 10 of 10 Vanguard fundsAgainstPassed (calculated), 93.0% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Alfred M. Rankin, Jr.WithholdFOR — 10 of 10 Vanguard fundsAgainstElected, 94.2% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Carolyn CorviWithholdFOR — 10 of 10 Vanguard fundsAgainstElected, 94.1% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Claiborne R. RankinWithholdFOR — 10 of 10 Vanguard fundsAgainstElected, 94.6% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Colleen R. BatchelerWithholdFOR — 10 of 10 Vanguard fundsAgainstElected, 95.0% support
Hyster-Yale, Inc.2026-05-12Election of Directors: David B.H. WilliamsWithholdFOR — 10 of 10 Vanguard fundsAgainstElected, 94.6% support
Hyster-Yale, Inc.2026-05-12Election of Directors: Dennis W. LaBarreWithholdFOR — 10 of 10 Vanguard fundsAgainstElected, 89.8% support
Hyster-Yale, Inc.2026-05-12Election of Directors: H. Vincent PoorWithholdFOR — 10 of 10 Vanguard fundsAgainstElected, 94.7% support
Hyster-Yale, Inc.2026-05-12Election of Directors: J.C. Butler, Jr.WithholdFOR — 10 of 10 Vanguard fundsAgainstElected, 92.1% support
Hyster-Yale, Inc.2026-05-12Election of Directors: John P. JumperWithholdFOR — 10 of 10 Vanguard fundsAgainstElected, 94.1% support
MGP Ingredients, Inc.2026-05-13Approve the MGP Ingredients, Inc. Amended and Restated 2024 Equity Incentive Plan.AgainstFOR — 10 of 10 Vanguard fundsAgainst—
MGP Ingredients, Inc.2026-05-13Election of Directors: Thomas A. GerkeAgainstFOR — 10 of 10 Vanguard fundsAgainstElected, 86.2% support
MGP Ingredients, Inc.2026-05-13Election of Directors: Todd B. SiwakAgainstFOR — 10 of 10 Vanguard fundsAgainstElected, 82.3% support
Upstream Bio, Inc.2026-06-09To elect two class II directors to Upstream's board of directors, each to serve until the 2029 annual meeting of Upstream's stockholders, and until his respective successor has been duly elected and qualified, or until his earlier death, resignation or removal: H. Edward Fleming, Jr., M.D.WithholdFOR — 10 of 10 Vanguard fundsAgainst—
Warner Bros. Discovery, Inc.2026-06-09ELECTION OF DIRECTORS: Anthony J. NotoForWITHHOLD — 20 of 22 Vanguard fundsForPassed (calculated), 59.2% support
Morgan Stanley2026-05-14Shareholder Shareholder proposal requesting an independent Board ChairmanForAGAINST — 31 of 36 Vanguard fundsAgainstFailed (calculated), 27.3% support
PayPal Holdings, Inc.2026-05-19Shareholder Stockholder Proposal - Reduce Threshold to Call Special Meetings of Stockholders.ForAGAINST — 27 of 31 Vanguard fundsAgainstNot approved, 41.3% support
Tyson Foods, Inc.2026-02-05Shareholder Shareholder proposal regarding disclosure of voting results based on class of shares.ForAGAINST — 27 of 31 Vanguard fundsAgainstFailed (calculated), 14.5% support
Tyson Foods, Inc.2026-02-05Election of Directors: David J. BronczekAgainstFOR — 27 of 31 Vanguard fundsAgainstPassed (calculated), 90.0% support
Advanced Micro Devices, Inc.2026-05-13Shareholder Stockholder proposal requesting changes to the stockholder right to call a special meeting.ForAGAINST — 26 of 30 Vanguard fundsAgainstNot approved, 37.5% support
Opendoor Technologies Inc.2026-06-11To elect three nominees to hold office as Class III members of our Board of Directors until the 2029 Annual Meeting of Stockholders: David BensonWithholdFOR — 9 of 9 Vanguard fundsAgainstPassed (calculated), 90.2% support
Opendoor Technologies Inc.2026-06-11To elect three nominees to hold office as Class III members of our Board of Directors until the 2029 Annual Meeting of Stockholders: Eric FederWithholdFOR — 9 of 9 Vanguard fundsAgainstPassed (calculated), 84.0% support
Novavax, Inc.2026-06-18The approval, on an advisory basis, of the compensation of our Named Executive Officers.AgainstFOR — 14 of 15 Vanguard fundsAgainstApproved, 50.7% support
Taysha Gene Therapies, Inc.2026-06-01To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.AgainstFOR — 14 of 15 Vanguard fundsAgainstPassed (calculated), 82.2% support
Evolent Health, Inc.2026-06-04Proposal to approve an amendment to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan,AgainstFOR — 9 of 9 Vanguard fundsAgainstApproved, 71.8% support
REGENXBIO Inc.2026-05-29Election of three Class II Directors: Jean Bennett, M.D., Ph.D.WithholdFOR — 9 of 9 Vanguard fundsAgainstElected, 68.1% support
REGENXBIO Inc.2026-05-29To approve a stock option exchange for our executive employees.AgainstFOR — 9 of 9 Vanguard fundsAgainst—
REGENXBIO Inc.2026-05-29To approve a stock option exchange for our non-executive employees.AgainstFOR — 9 of 9 Vanguard fundsAgainstApproved, 74.9% support
Cooper-Standard Holdings Inc.2026-05-14Election of Directors: Adriana E. Macouzet-FloresAgainstFOR — 9 of 9 Vanguard fundsAgainstElected, 63.2% support
Cooper-Standard Holdings Inc.2026-05-14Election of Directors: Richard J. FreelandAgainstFOR — 9 of 9 Vanguard fundsAgainstElected, 59.9% support
Cooper-Standard Holdings Inc.2026-05-14Election of Directors: Sonya F. SepahbanAgainstFOR — 9 of 9 Vanguard fundsAgainstElected, 61.8% support
Fulcrum Therapeutics, Inc.2026-06-24Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Sonja BanksWithholdFOR — 9 of 9 Vanguard fundsAgainstPassed (calculated), 80.3% support
Clearwater Paper Corporation2026-05-07Approve the Clearwater Paper Corporation 2026 Stock Incentive PlanAgainstFOR — 9 of 9 Vanguard fundsAgainstApproved, 54.7% support
James River Group Holdings, Ltd.2025-10-23To approve the amendment of the James River Group Holdings, Ltd. 2014 Non-Employee Director Incentive Plan.AgainstFOR — 9 of 9 Vanguard fundsAgainstPassed (calculated), 66.8% support
Organogenesis Holdings Inc.2026-06-15Election of Directors: Jon GiacominWithholdFOR — 9 of 9 Vanguard fundsAgainstPassed (calculated), 76.0% support
The Hain Celestial Group, Inc.2025-10-30Proposal to approve an amendment to the 2022 Long Term Incentive and Stock Award Plan.AgainstFOR — 9 of 9 Vanguard fundsAgainstApproved, 75.2% support
Nu Holdings Ltd.2025-09-08Elect David Velez Osorno, Anita Mary Sands, David Alexandre Marcus, Douglas Mauro Leone, Jacqueline Dawn Reses, Luis Alberto Moreno Mejia, Roberto de Oliveira Campos Neto, Rogerio Paulo Calderon Peres and Thuan Quang Pham as DirectorsAgainstFOR — 9 of 9 Vanguard fundsAgainst—
Omada Health, Inc.2026-06-16The election of two Class I directors to hold office until the 2029 Annual Meeting of Stockholders and until each such director's respective successor is elected and qualified: Sean DuffyWithholdFOR — 9 of 9 Vanguard fundsAgainst—
Omada Health, Inc.2026-06-16The election of two Class I directors to hold office until the 2029 Annual Meeting of Stockholders and until each such director's respective successor is elected and qualified: Trevor FetterWithholdFOR — 9 of 9 Vanguard fundsAgainst—
Broadcom Inc.2026-04-20Advisory vote to approve the named executive officer compensation.AgainstFOR — 38 of 46 Vanguard fundsAgainstApproved, 66.4% support
Tesla, Inc.2025-11-06Shareholder A shareholder proposal regarding proposal that won 54% support at 2024 Tesla annual meeting.ForAGAINST — 24 of 28 Vanguard fundsAgainstNot approved, 32.3% support
Tesla, Inc.2025-11-06A Tesla proposal for approval of the 2025 CEO Performance Award.AgainstFOR — 24 of 28 Vanguard fundsAgainstApproved, 77.0% support
FedEx Corporation2025-09-29Shareholder Stockholder proposal regarding independent board chairman.ForAGAINST — 24 of 28 Vanguard fundsAgainstNot approved, 42.5% support
Navitas Semiconductor Corporation2026-06-25The approval of an advisory resolution on the compensation of our named executive officers.AgainstFOR — 13 of 14 Vanguard fundsAgainstApproved, 77.3% support
IDEXX Laboratories, Inc.2026-05-12Shareholder Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six).ForAGAINST — 23 of 27 Vanguard fundsAgainst—
Brookfield Renewable Corporation2026-06-17Elect Director Jeffrey BlidnerWithholdFOR — 8 of 8 Vanguard fundsAgainst—
Chime Financial, Inc.2026-06-02Election of Class I Directors: Christopher BrittAgainstFOR — 8 of 8 Vanguard fundsAgainstElected, 96.7% support
Chime Financial, Inc.2026-06-02Election of Class I Directors: James DunneAgainstFOR — 8 of 8 Vanguard fundsAgainstElected, 96.4% support
Kiniksa Pharmaceuticals International, plc2026-05-29Election of Class II Directors to serve until the 2029 Annual General Meeting of Shareholders, and until their respective successors have been appointed or until their earlier resignation or vacation of office in accordance with Kiniksa's articles of association: Stephen R. BiggarAgainstFOR — 8 of 8 Vanguard fundsAgainstPassed (calculated), 75.7% support
Liquidia Corporation2026-06-16Election of Directors: Katie Rielly-GauvinWithholdFOR — 8 of 8 Vanguard fundsAgainstPassed (calculated), 92.2% support
Liquidia Corporation2026-06-16Election of Directors: Ramandeep SinghWithholdFOR — 8 of 8 Vanguard fundsAgainstPassed (calculated), 91.6% support
Tarsus Pharmaceuticals, Inc.2026-06-25To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Andrew GoldbergWithholdFOR — 8 of 8 Vanguard fundsAgainstElected, 76.9% support
Rigel Pharmaceuticals, Inc.2026-05-14To approve an amendment to our 2018 Equity Incentive Plan, as amended (the "Amended 2018 Plan"), to add an additional 500,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan.AgainstFOR — 8 of 8 Vanguard fundsAgainstApproved, 63.0% support
The Marcus Corporation2026-05-21Election of Directors: Austin M. RamirezWithholdFOR — 8 of 8 Vanguard fundsAgainstPassed (calculated), 95.1% support
The Marcus Corporation2026-05-21Election of Directors: Philip L. MilsteinWithholdFOR — 8 of 8 Vanguard fundsAgainstPassed (calculated), 92.3% support
The Marcus Corporation2026-05-21Election of Directors: Timothy E. HoeksemaWithholdFOR — 8 of 8 Vanguard fundsAgainstPassed (calculated), 94.3% support
CuriosityStream Inc.2026-05-20To approve an amendment to the CuriosityStream Inc. 2020 Omnibus Incentive Plan (the Plan) to increase the number of shares of Common Stock authorized for issuance under the Plan from 10,725,000 shares of Common Stock to 11,725,000 shares of Common Stock.AgainstFOR — 8 of 8 Vanguard fundsAgainstPassed (calculated), 81.8% support
CuriosityStream Inc.2026-05-20To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their respective successors are duly elected and qualified: Matthew BlankWithholdFOR — 8 of 8 Vanguard fundsAgainstPassed (calculated), 78.9% support
CuriosityStream Inc.2026-05-20To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their respective successors are duly elected and qualified: Mike NikzadWithholdFOR — 8 of 8 Vanguard fundsAgainstPassed (calculated), 86.1% support
Texas Instruments Incorporated2026-04-16Shareholder Stockholder proposal to permit stockholders to act by written consent.ForAGAINST — 32 of 39 Vanguard fundsAgainstFailed (calculated), 44.8% support
Snowflake Inc.2026-06-29To approve, on a non-binding advisory basis, the compensation of our named executive officers.AgainstFOR — 24 of 29 Vanguard fundsAgainstNot approved, 43.6% support
agilon health, inc.2026-06-02Election of Class II Directors: Karen McLoughlinAgainstFOR — 7 of 7 Vanguard fundsAgainstElected, 80.3% support
Ocular Therapeutix, Inc.2026-06-10To approve an advisory vote on named executive officer compensation.AgainstFOR — 11 of 12 Vanguard fundsAgainst—
Ocular Therapeutix, Inc.2026-06-10To elect two Class III directors, each to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Merilee RainesWithholdFOR — 7 of 7 Vanguard fundsAgainstElected, 86.9% support
Ocular Therapeutix, Inc.2026-06-10To elect two Class III directors, each to serve until the 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Pravin U. Dugel, M.D.WithholdFOR — 7 of 7 Vanguard fundsAgainstElected, 90.6% support
AMC Global Media Inc.2026-06-16Advisory vote on Named Executive Officer compensationAgainstFOR — 11 of 12 Vanguard fundsAgainstApproved, 88.9% support
3D Systems Corporation2026-05-14The approval of the amendment and restatement of the 2015 Incentive Plan to increase the number of shares reserved for issuance thereunder by 4,000,000 shares and to extend the term until 2036.AgainstFOR — 7 of 7 Vanguard fundsAgainstApproved, 70.7% support
Standard BioTools Inc.2026-06-17To approve the Standard BioTools Inc. 2026 Equity Incentive Plan.AgainstFOR — 7 of 7 Vanguard fundsAgainstApproved, 92.8% support
Standard BioTools Inc.2026-06-17To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement.AgainstFOR — 11 of 12 Vanguard fundsAgainstApproved, 85.2% support
RxSight, Inc.2026-06-16To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Robert WarnerWithholdFOR — 7 of 7 Vanguard fundsAgainst—
RxSight, Inc.2026-06-16To elect three Class II directors, to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Shweta Singh ManiarWithholdFOR — 7 of 7 Vanguard fundsAgainst—
Brookfield Infrastructure Corporation2026-06-24Elect Director Jeffrey BlidnerWithholdFOR — 7 of 7 Vanguard fundsAgainst—
Montauk Renewables, Inc.2026-05-26Election of two nominees to the Board of Directors to serve as Class III directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Sean F. McClainWithholdFOR — 7 of 7 Vanguard fundsAgainst—
Zevra Therapeutics, Inc.2026-06-04Election of Directors: Douglas W. CalderWithholdFOR — 7 of 7 Vanguard fundsAgainst—
Aurora Innovation, Inc.2026-05-21Election of Directors: Gloria BoylandWithholdFOR — 14 of 16 Vanguard fundsAgainstElected, 97.3% support
Lifeway Foods, Inc.2025-12-29To approve, by non-binding advisory vote, executive compensation.AgainstFOR — 10 of 11 Vanguard fundsAgainstApproved, 53.3% support
Oracle Corporation2025-11-18Elect Bruce R. ChizenWithholdFOR — 6 of 6 Vanguard fundsAgainst—
Oracle Corporation2025-11-18Elect Jeffrey O. HenleyWithholdFOR — 6 of 6 Vanguard fundsAgainst—
Coca-Cola Europacific Partners plc2026-05-28Approve Waiver of Rule 9 of the Takeover CodeAgainstFOR — 6 of 6 Vanguard fundsAgainst—
Coca-Cola Europacific Partners plc2026-05-28Re-elect Jose Ignacio Comenge as DirectorAgainstFOR — 6 of 6 Vanguard fundsAgainst—
Coca-Cola Europacific Partners plc2026-05-28Re-elect Manolo Arroyo as DirectorAgainstFOR — 6 of 6 Vanguard fundsAgainst—
Paymentus Holdings, Inc.2026-06-05Election of Directors: Adam MalinowskiWithholdFOR — 6 of 6 Vanguard fundsAgainstElected, 98.3% support
Paymentus Holdings, Inc.2026-06-05Election of Directors: Gary TrainorWithholdFOR — 6 of 6 Vanguard fundsAgainstElected, 97.7% support
Paymentus Holdings, Inc.2026-06-05Election of Directors: Jody DavidsWithholdFOR — 6 of 6 Vanguard fundsAgainstElected, 98.6% support
Array Digital Infrastructure, Inc.2025-10-09Election of Directors: E. C. IriarteWithholdFOR — 6 of 6 Vanguard fundsAgainstPassed (calculated), 94.0% support
Array Digital Infrastructure, Inc.2025-10-09Election of Directors: H. J. Harczak, Jr.WithholdFOR — 6 of 6 Vanguard fundsAgainstPassed (calculated), 91.4% support
Array Digital Infrastructure, Inc.2025-10-09Election of Directors: X. D. WilliamsWithholdFOR — 6 of 6 Vanguard fundsAgainstPassed (calculated), 94.0% support
Industrial Logistics Properties Trust2026-06-09Election of Trustees: Nominees (for Independent Trustee): Kevin C. PhelanWithholdFOR — 6 of 6 Vanguard fundsAgainstElected, 79.5% support
Industrial Logistics Properties Trust2026-06-09Election of Trustees: Nominees (for Independent Trustee): Lisa Harris JonesWithholdFOR — 6 of 6 Vanguard fundsAgainstElected, 70.9% support
Industrial Logistics Properties Trust2026-06-09Election of Trustees: Nominees (for Managing Trustee): Adam PortnoyWithholdFOR — 6 of 6 Vanguard fundsAgainstElected, 69.9% support
Seritage Growth Properties2026-06-09The election of John T. McClain, Adam Metz, Talya Nevo-Hacohen, Mitchell Sabshon, Allison L. Thrush and Mark Wilsmann as trustees, each to serve until the 2027 annual meeting of shareholders and until his or her successor is duly elected and qualifies: Allison L. ThrushAgainstFOR — 6 of 6 Vanguard fundsAgainstPassed (calculated), 53.2% support
Seritage Growth Properties2026-06-09The election of John T. McClain, Adam Metz, Talya Nevo-Hacohen, Mitchell Sabshon, Allison L. Thrush and Mark Wilsmann as trustees, each to serve until the 2027 annual meeting of shareholders and until his or her successor is duly elected and qualifies: John T. McClainAgainstFOR — 6 of 6 Vanguard fundsAgainstPassed (calculated), 53.2% support
Seritage Growth Properties2026-06-09The election of John T. McClain, Adam Metz, Talya Nevo-Hacohen, Mitchell Sabshon, Allison L. Thrush and Mark Wilsmann as trustees, each to serve until the 2027 annual meeting of shareholders and until his or her successor is duly elected and qualifies: Mark WilsmannAgainstFOR — 6 of 6 Vanguard fundsAgainstPassed (calculated), 53.2% support
Seritage Growth Properties2026-06-09The election of John T. McClain, Adam Metz, Talya Nevo-Hacohen, Mitchell Sabshon, Allison L. Thrush and Mark Wilsmann as trustees, each to serve until the 2027 annual meeting of shareholders and until his or her successor is duly elected and qualifies: Mitchell SabshonAgainstFOR — 6 of 6 Vanguard fundsAgainstPassed (calculated), 53.2% support
Seritage Growth Properties2026-06-09The election of John T. McClain, Adam Metz, Talya Nevo-Hacohen, Mitchell Sabshon, Allison L. Thrush and Mark Wilsmann as trustees, each to serve until the 2027 annual meeting of shareholders and until his or her successor is duly elected and qualifies: Talya Nevo-HacohenAgainstFOR — 6 of 6 Vanguard fundsAgainstPassed (calculated), 53.2% support
FutureFuel Corp.2025-11-11To elect two directors of the Corporation to serve a three-year term expiring 2028: Donald C. BedellWithholdFOR — 6 of 6 Vanguard fundsAgainst—
FutureFuel Corp.2025-11-11To elect two directors of the Corporation to serve a three-year term expiring 2028: Ronald J. KruszewskiWithholdFOR — 6 of 6 Vanguard fundsAgainst—
Eli Lilly and Company2026-05-04Shareholder Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair.ForAGAINST — 27 of 37 Vanguard fundsAgainstNot approved, 33.7% support
Chevron Corporation2026-05-27Election of Directors: Jon M. Huntsman Jr.AgainstFOR — 5 of 5 Vanguard fundsAgainst—
Aebi Schmidt Holding AG2026-05-21Election of Barend Fruithof as the Chair of the Board of DirectorsAgainstFOR — 5 of 5 Vanguard fundsAgainstPassed (calculated), 96.3% support
GFL Environmental Inc.2026-05-13Re-approve Deferred Share Unit PlanAgainstFOR — 5 of 5 Vanguard fundsAgainst—

48 more in the CSV.

Download all 548 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 93.8% of this fund’s 8,268 such votes could be given a sector; the other 514 (6.2%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary1,349624.6%
Technology1,258705.6%
Industrials1,240413.3%
Health Care1,112252.2%
Finance1,068353.3%
Utilities419133.1%
Energy31541.3%
Real Estate30220.7%
Consumer Staples295196.4%
Telecommunications20673.4%
Basic Materials12710.8%
Miscellaneous6300.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections6,02611
Audit-related7140
Say-on-Pay7074
Corporate Governance31999
Compensation29010
Capital Structure1171
Shareholder Rights and Defenses6027
Other Social Issues5747
Environment or Climate5453
Extraordinary Transactions372

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Apple Inc.February 24, 2026$2.5B201
Microsoft CorporationDecember 5, 2025$2.4B245
NVIDIA CorporationJune 24, 2026$1.9B264
Amazon.com, Inc.May 20, 2026$1.2B173
Broadcom Inc.April 20, 2026$1.1B120
Alphabet Inc.June 5, 2026$965M358
Micron Technology, Inc.January 15, 2026$881M121
Eli Lilly and CompanyMay 4, 2026$869M101

Notable votes against management

MeetingCompanyProposalFundMgmt
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding a report on water usage and AI development Shareholder proposalAgainstFor
January 15, 2026Micron Technology, Inc.SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst
June 16, 2026Mastercard IncorporatedConsideration of a stockholder proposal to adopt cumulative voting for the election of directors Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (3 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

8,415 ballot items at 729 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Vanguard Growth and Income Fund (VGIAX) voted at 729 shareholder meetings of 710 companies, on 8,415 ballot items in all. Where management made a recommendation, the fund followed it on 96.6% of the items and voted against it 281 times. Its most frequent area of disagreement was corporate governance (99 of its votes against management). It voted FOR 37.7% of the 268 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than Vanguard's funds as a whole (92.6% against 94.5%). It voted differently from most Vanguard funds on 548 items. 3 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Vanguard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.